Real-time enrollment status for this alzheimer disease clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 11:13 PM UTC
| NCT Number | NCT06254469 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer Disease |
| Phase | PHASE3 |
| Target Enrollment | 230 participants |
| Active Locations | 1 sites in the US |
| Sponsor | CereMark Pharma, LLC |
| Last Updated on CT.gov | July 30, 2025 (Jul 30, 2025) |
As of July 19, 2026: Clinical trial NCT06254469 is currently recruiting participants. This phase3 study for alzheimer disease is actively seeking new participants at 1 location across the United States. The study is sponsored by CereMark Pharma, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06254469 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06254469 was last updated Jul 30, 2025 (July 30, 2025). HelloStudys verifies this status automatically.